Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by GrahamBon Jan 10, 2025 11:18am
135 Views
Post# 36398049

Robbing Peter to Pay Paul?

Robbing Peter to Pay Paul?

VPT appears to be managing liquidity challenges by issuing shares to satisfy obligations Of the debenture interest.
 

While this is good to help conserve cash, it raises concerns about financial stability, as they had negative working capital(1149698 in June)  as I understand it and can’t close the financing . They had about 300k left in June and sales remain minimal so the rubber does hit the road at some point.
 

Not sure what this means for investor confidence but suggest to me paying Peter to pay a Paul so to speak

 

“Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”), (TSXV:VPT) announces it will satisfy debenture interest payment obligation with the issuance of common shares, subject to TSX Venture Exchange (“TSXV”) approval. The Corporation will issue an aggregate of up to 83,864 common shares (“Shares”) for the payment of an aggregate of $9,225.20 of interest on certain outstanding Convertible Debentures issued by the Corporation on June 28, 2024. The Convertible Debentures bear interest at the rate of 10% per annum, payable every 6 months. The Shares will be issued at a deemed price of $0.11, subject to the approval of TSXV and are subject to a hold period of 4 months and one day. The issuance of the Shares will not create a control person of the Corporation.” Source :VPT news release

 

2025-01-10 | Ventripoint Issues Shares for Payment of Debenture Interest | TSXV:VPT | Press Release

 

All imo

FWIW

Do you own dd

For education and interest only not to invest  

<< Previous
Bullboard Posts
Next >>